Ifetroban
Ifetroban for Treating DMD-Associated Cardiomyopathy
Feb 12, 2020 at 10:06 am by Staff
Cumberland Pharmaceuticals Gears up for Phase II Clinical Trial
Last fall, the U.S. Food and Drug Administration (FDA) announced $15 million in grant funding in support of 12.... Read More
From Clinical Trial to Commercialization
Nov 03, 2016 at 03:07 pm by Staff
It's a long road with many speed bumps along the way when making the journey from drug development to approval and commercialization, but Nashville-based Cumberland Pharmaceut.... Read More